BioNJ’s Federal Policy Committee

Marty Whalen, Chair
Senior Vice President, Global Policy and Government Affairs
Bristol Myers Squibb

Chris Bowlin
Executive Director, Head
Public Policy &
Government Affairs
CorMedix

Nick Braughton
Senior Manager
Government Affairs
PTC Therapeutics

Tricia Brooks
Vice President
Government Affairs & Policy
Eisai

Elizabeth Brooks
U.S. Government
Affairs & Policy
Eisai

Becca Davison
Director, US Public Policy
BeOne Medicines

Becca Durr
Director of Federal
Government Affairs
Novartis Pharmaceuticals

Tegan Gelfand
Senior Director
Government Affairs
Ferring Pharmaceuticals

Paul Howard, Ph.D.
Executive Director
Public Policy & Corp. Affairs
Amicus Therapeutics

Susan Levinson
CEO
BioAegis Therapeutics

Timothy Lyden
Director
State Government Affiliate
Eli Lilly & Company

Mike Mattoon
Vice President, Government
Affairs and Policy
Acadia Pharmaceuticals

Jessica Nagro
Director
Alliance Development
Regeneron

Theodore Piper
Associate Director
State Government Affairs
PTC Therapeutics

Berrett Stradford
Director
Issue Advocacy & Alliances
Genetech

Timothy Swope
Director, Pharmaceuticals, U.S. Federal Affairs
Johnson & Johnson

Brad Tallamy
Executive Director, US Policy & Government Relations
Merck

Sarah Tellock
Director, Federal Affairs & Alliance Development
Alzheimer’s Association

Richard White
Director, Government Affairs
Gilead Sciences

Joseph Zorzoli
Senior Director
Head, Government Affairs
Genmab